Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Active, not recruiting · NCT00539591 · Registry updated 2026-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 2 | 2026-06-25 | NCT00539591 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Schering-Plough | 2 |
| St. Jude Children's Research Hospital | 169 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rady Children's Hospital | San Diego | United States | 52 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |
| The Children's Cancer Hospital at UT M.D. Anderson Cancer Center | Houston | United States | 1 |